Perindopril: the “blood vessel guardian” among antihypertensive drugs

Perindopril is an angiotensin-converting enzyme inhibitor (ACEI), mainly used to treat hypertension and heart failure, and has both cardiovascular and renal protection effects. Its core advantage lies in long-term and stable blood pressure reduction while reducing the risk of complications. The content will revolve aroundMechanism of action, indications, medication precautions and common products on the marketExpand and prioritize to help readers fully understand this drug.

Mechanism of action and core efficacy

Perindopril inhibits angiotensin-converting enzyme and reduces the production of the vasoconstrictor substance "angiotensin II", thereby dilating blood vessels and lowering blood pressure. In addition, it can reduce the load on the heart and improve cardiac function in patients with heart failure. Studies have shown that long-term use can reduce the risk of myocardial infarction and stroke (quoted from "China Guidelines for the Prevention and Treatment of Hypertension"). its uniqueorganizational affinityThe effect lasts for more than 24 hours, making it suitable for taking once a day.

Indications and applicable groups

Perindopril is suitable for patients with essential hypertension, chronic heart failure and diabetic nephropathy. especially forHypertensive patients with diabetes and coronary heart diseaseIt is more advantageous because it can reduce proteinuria and delay the deterioration of renal function. However, it should be noted that it is contraindicated in pregnant women and those with bilateral renal artery stenosis. The drug may cause dry cough (a common side effect of ACEI) in the early stage of use. Most of the drugs are tolerable. If necessary, the plan needs to be adjusted according to the doctor's advice.

Medication precautions and combination therapy

Taking perindopril requires regular monitoring of blood pressure, serum potassium and kidney function. Avoid concomitant use with potassium-sparing diuretics (such as spironolactone) to prevent hyperkalemia. Clinically, it is often used in combination with thiazide diuretics (such as hydrochlorothiazide) to enhance the antihypertensive effect. The famous cardiovascular expert Hu Dayi once pointed out: "ACEI is the cornerstone drug for patients with hypertension and heart failure, but the dose needs to be adjusted individually." (Quoted from "Cardiology Practice")

Summary and common product information

As a first-line antihypertensive drug, Perindopril takes into account both efficacy and organ protection, but medical advice must be strictly followed. The following table lists common domestic manufacturers and products:

Sources cited: 1. "China Guidelines for the Prevention and Treatment of Hypertension" (2023 revised edition); 2. Hu Dayi's "Cardiology Practice"; 3. State Food and Drug Administration approval information.